ALCAM and Ewing sarcoma: Previous works have suggested a potentially regulatory role for miR-21 in ES pathogenesis by targeting Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166), whose expression is characteristic of tumourigenicity 176.